These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3461171)

  • 1. HTLV-III ELISA testing of cadaveric sera to screen potential organ transplant donors.
    Pepose JS; Pardo FS; Donegan E; Quinn TC
    JAMA; 1986 Aug; 256(7):864. PubMed ID: 3461171
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening cornea donors for antibodies against human immunodeficiency virus. Efficacy of ELISA testing of cadaveric sera and aqueous humor.
    Pepose JS; Pardo F; Kessler JA; Kline R; Donegan E; Quinn TC
    Ophthalmology; 1987 Feb; 94(2):95-100. PubMed ID: 3554092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III.
    Gürtler LG; Eberle J; Lorbeer B; Deinhardt F
    J Virol Methods; 1987 Jan; 15(1):11-23. PubMed ID: 3468119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
    Abb J
    AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of eight ELISA kits for the detection of anti-LAV/HTLV-III antibodies.
    Courouce AM
    Lancet; 1986 May; 1(8490):1152-3. PubMed ID: 2871401
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
    Heinz FX; Kunz C; Barrett N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of ELISA in the diagnosis of HTLV-III-LAV infection. Specificity of kits].
    Lazizi Y; Guetard D; Pillot J
    Presse Med; 1986 Dec; 15(43):2169. PubMed ID: 2954072
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-HTLV-III testing--a practical solution for blood transfusion services?
    Milner LV; Vorster BJ; Conradie JD; Brain P
    S Afr Med J; 1985 Dec; 68(13):921-2. PubMed ID: 3001948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of HTLV-III antibody in cerebrospinal fluid from patients with AIDS and pre-AIDS with the use of a commercial test system.
    Johnson JE; Zolla-Pazner S
    Am J Clin Pathol; 1987 Sep; 88(3):351-3. PubMed ID: 3477084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Two Enzyme-Linked Immunosorbent Assay Kits for Chikungunya Virus IgM Using Samples from Deceased Organ and Tissue Donors.
    Prince HE; Altrich ML; Nowicki MJ
    Clin Vaccine Immunol; 2016 Oct; 23(10):825-830. PubMed ID: 27535838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donors.
    Bryan CF; Tegtmeier GE; Polito A; Bayer W; Pierce GE; Shield CF; Warady BA; Aeder MI; Borkon AM; Estep TH; Forster J; Landreneau MD; Luger AM; Nelson PW; Ross G
    Transplant Proc; 1996 Feb; 28(1):155-6. PubMed ID: 8644153
    [No Abstract]   [Full Text] [Related]  

  • 12. [Detection of HTLV-III antibodies using ELISA and the western blot].
    Kunz C; Heinz FX
    Wien Klin Wochenschr; 1985 Nov; 97(22):829-32. PubMed ID: 3002046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-III testing of donor blood imminent; complex issues remain.
    Goldsmith MF
    JAMA; 1985 Jan; 253(2):173-5, 179-81. PubMed ID: 2981368
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C virus in cadaver organ donors: prevalence and risk of transmission to transplant recipients.
    Vincenti F; Weber P; Kuo G; Forsell J; Hunt S; Melzer J; Salvatierra O; Stempel C
    Transplant Proc; 1991 Oct; 23(5):2651-2. PubMed ID: 1656566
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies to human immunodeficiency virus (HTLV-III/LAV) in people from Lagos and Cross River States of Nigeria.
    Okpara RA; Akinsete I; Williams EE; Schneider J; Wendler I; Hunsmann G
    Acta Haematol; 1988; 79(2):91-3. PubMed ID: 3124480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is an "equivocal" negative HTLV-III antibody test in blood donors?
    Barclay GR; Hopcroft W; McClelland DB
    Lancet; 1986 Apr; 1(8486):912-3. PubMed ID: 2870379
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-HTLV-III screening specificity and sensitivity.
    Barr A; Dow BC; Arnott J; Crawford RJ; Mitchell R
    Lancet; 1986 May; 1(8488):1032. PubMed ID: 2871308
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of three commercial kits for the confirmation of antibodies to human immunodeficiency virus (HIV-1).
    Pearson SD; Wittwer CT; Ash KO
    Clin Chem; 1988 Sep; 34(9):1930. PubMed ID: 3166415
    [No Abstract]   [Full Text] [Related]  

  • 19. A UK survey of virological testing of cadaver tissue donors. Microbiology Working Group of the NIBSC steering group on Tissue/Cell Banking and Engineering.
    Stanworth SJ; Warwick RM; Ferguson M; Barbara JA
    Vox Sang; 2000; 79(4):227-30. PubMed ID: 11155074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA testing for diagnosis of retroviral infections in the Caribbean.
    Ridel PR; Artus JC; Capron A
    Bull Pan Am Health Organ; 1991; 25(3):201-6. PubMed ID: 1742565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.